Name: Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic
Start: 2020-12-10T19:00:00-05:00
End: 2020-12-10T20:00:00-05:00

Early Clinical Signs of Severe Lassa Fever

CEPI-EDCTP Seeks Proposals for Lassa Virus Vaccines

by Global Biodefense Staff February 23, 2020, 10:06 am
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

by Global Biodefense Staff January 23, 2020, 9:07 pm
British Nationals Evacuated from Sierra Leone for Lassa Fever Contact Monitoring

by Global Biodefense Staff November 24, 2019, 6:51 pm
Deforestation Leading to More Infectious Diseases in Humans

by Global Biodefense Staff November 22, 2019, 9:51 am
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents

by Global Biodefense Staff September 21, 2018, 5:01 am
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons

by Global Biodefense Staff September 21, 2018, 4:28 am
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses

by Global Biodefense Staff October 10, 2017, 3:24 pm
New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah

by Global Biodefense Staff January 19, 2017, 10:29 am
Zalgen and NOWDx Collaborate on Rapid Diagnostics for Ebola, Tropical Diseases

by Global Biodefense Staff November 3, 2016, 10:04 am
WHO Update: Lassa Fever in Germany

by Global Biodefense Staff March 23, 2016, 10:32 am
Advanced Development of Filovirus and Lassa Fever Vaccines

by Global Biodefense Staff March 13, 2016, 4:01 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Handicapping Ebola to Buy Immune System Time to Respond

by Global Biodefense Staff November 2, 2015, 9:24 am
RFI – Vaccine Candidates and Technologies for Filoviruses

by Global Biodefense Staff August 18, 2015, 10:28 am
CDC Confirms Lassa Fever in Death of New Jersey Man

by Global Biodefense Staff May 26, 2015, 9:35 am

Congratulations. You've reached the end of the internet.

Lassa Fever

Early Clinical Signs of Severe Lassa Fever

Lassa Fever: Why There’s a Call to Declare a Health Emergency in Nigeria

CDC Updates Monkeypox Travel Alert for Nigeria

U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone

CEPI-EDCTP Seeks Proposals for Lassa Virus Vaccines

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

British Nationals Evacuated from Sierra Leone for Lassa Fever Contact Monitoring

Deforestation Leading to More Infectious Diseases in Humans

Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents

Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons

NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses

New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah

Zalgen and NOWDx Collaborate on Rapid Diagnostics for Ebola, Tropical Diseases

WHO Update: Lassa Fever in Germany

Advanced Development of Filovirus and Lassa Fever Vaccines

Handicapping Ebola to Buy Immune System Time to Respond

RFI – Vaccine Candidates and Technologies for Filoviruses

CDC Confirms Lassa Fever in Death of New Jersey Man

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

Testing Sewage Can Give Schools and Businesses a Heads-Up on the Spread of COVID-19

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS-CoV-2 from Military Aircraft

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

Latest stories

Latest Articles